SNT 2.22% 4.4¢ syntara limited

Ann: Pharmaxis Announces LOXL2 Program Phase 2 Ready, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,135 Posts.
    lightbulb Created with Sketch. 546

    Great news! although a few weeks delay.

    Now the program is on the shelf for a sell.


    Hello big pharmas, will you pay a billion plus for this good drug?

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.